KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Asset Writedowns and Impairment (2016 - 2026)

Idexx Laboratories has reported Asset Writedowns and Impairment over the past 15 years, most recently at $250000.0 for Q1 2024.

  • For Q1 2024, Asset Writedowns and Impairment changed N/A year-over-year to $250000.0; the TTM value through Dec 2024 reached $250000.0, down 83.15%, while the annual FY2024 figure was $250000.0, 83.15% down from the prior year.
  • Asset Writedowns and Impairment for Q1 2024 was $250000.0 at Idexx Laboratories, down from $1.5 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $2.0 million in Q3 2020 and troughed at $250000.0 in Q1 2024.
  • A 4-year average of $1.1 million and a median of $1.3 million in 2021 define the central range for Asset Writedowns and Impairment.
  • Biggest five-year swings in Asset Writedowns and Impairment: tumbled 47.52% in 2020 and later plummeted 34.77% in 2021.
  • Year by year, Asset Writedowns and Impairment stood at $508000.0 in 2020, then soared by 155.91% to $1.3 million in 2021, then rose by 14.15% to $1.5 million in 2023, then tumbled by 83.15% to $250000.0 in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for IDXX at $250000.0 in Q1 2024, $1.5 million in Q4 2023, and $1.3 million in Q3 2021.